GlassScriptPhysician profile
Aaron Lee Doonan
NPI 1164614574
$7,861.40
in general payments reported to CMS, 2019-2025
31 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,247 · 2020: $188 · 2021: $826 · 2022: $1,308 · 2023: $1,539 · 2024: $1,393 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,200 · Education: $90.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,200.37 |
| Education | $90.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $998.68 | 2019-2025 | Watchman Access System, Watchman Flx, Emerge Push |
| Shockwave Medical, INC | $933.97 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $862.43 | 2019-2025 | Pressurewire, Dragonfly Opstar, Cardiomems |
| Medtronic, INC. | $824.49 | 2021-2024 | Resolute Onyx, Ffrangio, Corevalve Evolut R |
| Abiomed | $788.68 | 2019-2025 | Impella |
| Livanova USA, INC. | $633.64 | 2019-2022 | |
| Medtronic Vascular, INC. | $411.22 | 2019-2020 | |
| Cardiva Medical, INC. | $336.54 | 2023-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.98 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $246.63 | 2021-2025 | |
| Novo Nordisk INC | $206.68 | 2023-2024 | Ozempic, Wegovy, Rybelsus |
| Penumbra, INC. | $196.18 | 2025 | Indigo System, Penumbra System |
| Pfizer INC. | $173.11 | 2021-2024 | |
| Amgen INC. | $149.43 | 2019-2024 | Repatha |
| Teleflex LLC | $135.09 | 2022-2024 | Guideliner, Manta |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $104.31 | 2023-2024 | Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $97.47 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $86.71 | 2021-2025 | Eliquis, Camzyos |
| Philips North America LLC | $74.98 | 2020-2025 | Coronary Other |
| Merck Sharp & Dohme LLC | $65.05 | 2021 | |
| Stryker Corporation | $64.63 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $40.70 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $30.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.89 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $21.41 | 2022 | |
| Inari Medical, INC. | $18.21 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $16.64 | 2024 | Orsiro Mission |
| Actelion Pharmaceuticals US, INC. | $12.69 | 2021 | |
| Cvrx, INC. | $10.11 | 2022 | |
| Cardiovascular Systems INC. | $9.10 | 2023 | Diamondback Coronary |
| Osprey Medical INC | $5.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Doonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.